rs1450092

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000844.4(GRM7):​c.1515+2696A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.175 in 152,164 control chromosomes in the GnomAD database, including 2,436 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.18 ( 2436 hom., cov: 31)

Consequence

GRM7
NM_000844.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.192

Publications

2 publications found
Variant links:
Genes affected
GRM7 (HGNC:4599): (glutamate metabotropic receptor 7) L-glutamate is the major excitatory neurotransmitter in the central nervous system, and it activates both ionotropic and metabotropic glutamate receptors. Glutamatergic neurotransmission is involved in most aspects of normal brain function and can be perturbed in many neuropathologic conditions. The metabotropic glutamate receptors are a family of G protein-coupled receptors that have been divided into three groups on the basis of sequence homology, putative signal transduction mechanisms, and pharmacologic properties. Group I includes GRM1 and GRM5, and these receptors have been shown to activate phospholipase C. Group II includes GRM2 and GRM3, while Group III includes GRM4, GRM6, GRM7 and GRM8. Group II and III receptors are linked to the inhibition of the cyclic AMP cascade but differ in their agonist selectivities. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2009]
GRM7 Gene-Disease associations (from GenCC):
  • neurodevelopmental disorder with seizures, hypotonia, and brain imaging abnormalities
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.356 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000844.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GRM7
NM_000844.4
MANE Select
c.1515+2696A>G
intron
N/ANP_000835.1Q14831-1
GRM7
NM_181874.3
c.1515+2696A>G
intron
N/ANP_870989.1Q14831-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GRM7
ENST00000357716.9
TSL:1 MANE Select
c.1515+2696A>G
intron
N/AENSP00000350348.4Q14831-1
GRM7
ENST00000389336.8
TSL:1
c.1515+2696A>G
intron
N/AENSP00000373987.4Q14831-5
GRM7
ENST00000389335.7
TSL:1
n.1515+2696A>G
intron
N/AENSP00000373986.3Q14831-4

Frequencies

GnomAD3 genomes
AF:
0.175
AC:
26630
AN:
152046
Hom.:
2431
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.147
Gnomad AMI
AF:
0.201
Gnomad AMR
AF:
0.172
Gnomad ASJ
AF:
0.226
Gnomad EAS
AF:
0.117
Gnomad SAS
AF:
0.370
Gnomad FIN
AF:
0.189
Gnomad MID
AF:
0.212
Gnomad NFE
AF:
0.179
Gnomad OTH
AF:
0.167
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.175
AC:
26673
AN:
152164
Hom.:
2436
Cov.:
31
AF XY:
0.177
AC XY:
13203
AN XY:
74410
show subpopulations
African (AFR)
AF:
0.147
AC:
6093
AN:
41514
American (AMR)
AF:
0.172
AC:
2627
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.226
AC:
785
AN:
3470
East Asian (EAS)
AF:
0.118
AC:
611
AN:
5182
South Asian (SAS)
AF:
0.371
AC:
1786
AN:
4818
European-Finnish (FIN)
AF:
0.189
AC:
1998
AN:
10590
Middle Eastern (MID)
AF:
0.201
AC:
59
AN:
294
European-Non Finnish (NFE)
AF:
0.179
AC:
12164
AN:
67998
Other (OTH)
AF:
0.174
AC:
367
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1129
2259
3388
4518
5647
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
306
612
918
1224
1530
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.174
Hom.:
955
Bravo
AF:
0.164
Asia WGS
AF:
0.292
AC:
1016
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
6.3
DANN
Benign
0.84
PhyloP100
0.19
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1450092; hg19: chr3-7506105; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.